pearlmatrix p-15 peptide enhanced bone graft 15L - Cerapedics P-15L (PearlMatrix TM P-15 Peptide Enhanced Bone Graft PearlMatrix P-15 Peptide Enhanced Bone Graft: Revolutionizing Spinal Fusion

Pearl matrixBone Graft The field of spinal fusion surgery has seen remarkable advancements, with innovative materials playing a crucial role in improving patient outcomes2025年8月14日—In June 2025, the company secured FDA premarket approval for itsPearlMatrix™P-15 Peptide Enhanced Bone Graft— and now they've marked another .... Among these, the PearlMatrix P-15 Peptide Enhanced Bone Graft stands out as a pioneering solution designed to accelerate and enhance the process of intervertebral body fusion.2025年7月8日—PearlMatrix Bone Graft is aClass III drug/device combination product for lumbar fusion. Of the more than 350 spinal bone grafts in the U.S. ... Developed by Cerapedics, this bone graft utilizes a unique peptide technology to promote cellular activity and bone regeneration, offering a significant advantage over traditional grafting methods.

Understanding the PearlMatrix P-15 Peptide Enhanced Bone Graft

The PearlMatrix P-15 Peptide Enhanced Bone Graft is a Class III drug-device combination product for lumbar fusion. Its core innovation lies in the incorporation of the P-15 Peptide, a synthetic 15-amino acid polypeptide sequence that mirrors a naturally occurring segment of human Type I collagen. This peptide acts as a potent cell attachment factor, initiating and accelerating the cascade of biological events necessary for successful bone healing.

The P-15 Peptide is designed to bind to osteogenic cells on the graft surfacePearlMatrix P-15 Peptide Enhanced Bone GraftShows Improved Fusion Rates and Safety. View organization page for Cerapedics Inc. Cerapedics .... Once bound, it activates these cells, which in turn stimulate progenitor cells to differentiate into osteoblastsClass 2 Device Recall PearlMatrix" P15 Peptide Enhanced .... These osteoblasts are then encouraged to produce new bone tissue, effectively promoting osteoconduction and osteoinduction2026年1月13日—PearlMatrix is now the onlyClass III drug-device spinal bone graftapproved for all major lumbar interbody surgical approaches in addition .... This mechanism significantly speeds up the bone formation process, leading to faster and more robust fusion.

Clinical Efficacy and FDA Approval

The effectiveness and safety of the PearlMatrix P-15 Peptide Enhanced Bone Graft have been rigorously evaluated through extensive clinical trials. Cerapedics has announced numerous milestones, including US Food and Drug Administration (FDA) premarket approval for this groundbreaking product.US FDA Approves PearlMatrix P-15 for Expanded Indications The PearlMatrix has been recognized as the first and only bone growth accelerator proven to accelerate lumbar fusion.What Is the Best Graft Material for Bone Regeneration? | Poway Perio

Studies, such as the ASPIRE study, have demonstrated that PearlMatrix achieved superior clinical success and time-to-fusion at 24 months compared to local autograft. Furthermore, research has indicated that PearlMatrix P-15 Peptide Enhanced Bone Graft shows improved fusion rates and safety. The P-15L (PearlMatrix TM P-15 Peptide Enhanced Bone Graft) has been evaluated in studies to determine if it is non-inferior in effectiveness to local autograft, with promising results.PearlMatrix | Cerapedics Corporate In one such study, the objective was to compare the time-to-fusion in patients treated with P-15L (PearlMatrix P-15 Peptide Enhanced Bone Graft) versus local autograft, with the PearlMatrix P-15 Peptide Enhanced Bone Graft demonstrating faster fusion times.

The PearlMatrix is indicated for intervertebral body fusion of the spine in skeletally mature patients. It is approved for all major lumbar interbody surgical approaches, highlighting its versatility and broad applicabilityThispeptidebinds to and activate osteogenic cells which then activate and encourage the conversion of progenitor cells to osteoblasts which are stimulated to .... The P-15L, an FDA-designated breakthrough device, underscores the innovative nature and significant clinical impact of this bone graft.作者：JS Harrop·2025·被引用次数：1—To evaluate whetherP-15L (PearlMatrix P-15 Peptide Enhanced Bone Graft) is noninferior in effectiveness to local autograft when applied in single-level ...

Key Features and Benefits

The PearlMatrix P-15 Peptide Enhanced Bone Graft offers several key advantages:

* Accelerated Fusion: The P-15 Peptide significantly speeds up the fusion process, reducing the time patients spend in recovery and potentially enabling earlier mobilization.

* Enhanced Cellular Activity: It actively promotes cell adhesion, proliferation, and differentiation, leading to robust bone regeneration2025年6月23日—Powered by a proprietary P-15 Osteogenic Cell Binding Peptide,PearlMatrix Bone Graftis the first and only bone growth accelerator (BGA) proven ....

* Proven Clinical Success: Backed by rigorous Level 1 human clinical data, the PearlMatrix has demonstrated superior clinical outcomes.2025年12月17日—Study results demonstrated thatPearlMatrix achieved superior clinical success and time-to-fusion at 24 monthscompared to local autograft.

* FDA Approved: As a Class III FDA approved bone graft, it meets stringent regulatory standards for safety and efficacy.

* Versatile Application: Approved for various lumbar interbody fusion procedures, it provides a reliable option for surgeons.

* Synthetic Peptide: The use of a synthetic peptide eliminates the risks associated with allograft or autograft procurement.

Comparison with Other Graft Materials

When considering bone graft options, the PearlMatrix P-15 Peptide Enhanced Bone Graft distinguishes itself from traditional autografts and other synthetic materials. Autografts, while considered the gold standard, involve a second surgical site, increasing patient morbidity and operative time. Other synthetic grafts may lack the biological signaling capabilities of the P-15 Peptide to actively promote cellular activity. The i-FACTOR P-15 Peptide is another product that utilizes similar peptide technology, highlighting the efficacy of this approach in bone regeneration.PearlMatrix P-15 Peptide Enhanced Bone Graft - MEARIS - CMS

Future of Bone Grafting

The development of PearlMatrix P-15 Peptide Enhanced Bone Graft signifies a paradigm shift in spinal fusion surgery. By harnessing the power of peptides, surgeons now have access to a bone graft that not only provides a scaffold for bone growth but actively participates in the biological process. The continued research and development in this area, exemplified by products like i-FACTOR P-15 Peptide, promise further advancements in accelerating bone healing and improving patient quality of life. The PearlMatrix is a testament to the ongoing innovation by Cerapedics in the pursuit of better surgical solutions.